CorVel Co. (NASDAQ:CRVL) Short Interest Update

CorVel Co. (NASDAQ:CRVL) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 760,700 shares, a decrease of 21.8% from the January 31st total of 973,200 shares. Based on an average daily volume of 118,400 shares, the short-interest ratio is currently 6.4 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of CorVel from a “hold” rating to a “buy” rating in a report on Wednesday, February 26th.

CorVel Trading Up 1.2 %

Shares of CorVel stock traded up $1.30 during trading on Wednesday, hitting $108.57. The stock had a trading volume of 37,955 shares, compared to its average volume of 102,976. CorVel has a 12 month low of $76.20 and a 12 month high of $128.61. The firm has a market cap of $5.58 billion, a price-to-earnings ratio of 63.79 and a beta of 1.16. The business’s 50-day moving average is $117.82 and its 200 day moving average is $114.10.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Insider Activity at CorVel

In related news, Director Alan Hoops sold 10,200 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the sale, the director now owns 118,213 shares of the company’s stock, valued at approximately $13,758,811.07. This represents a 7.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Mark E. Bertels sold 1,050 shares of CorVel stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $119.12, for a total value of $125,072.50. Following the transaction, the executive vice president now directly owns 2,580 shares of the company’s stock, valued at $307,321. The trade was a 28.93 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,773 shares of company stock worth $2,729,140. Insiders own 47.57% of the company’s stock.

Institutional Investors Weigh In On CorVel

A number of institutional investors and hedge funds have recently bought and sold shares of CRVL. LGT Financial Advisors LLC grew its stake in CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock worth $28,000 after buying an additional 170 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of CorVel by 6,350.0% during the 4th quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock worth $29,000 after acquiring an additional 254 shares during the last quarter. Fifth Third Bancorp lifted its holdings in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares during the last quarter. Jones Financial Companies Lllp purchased a new position in CorVel in the fourth quarter worth $37,000. Finally, US Bancorp DE increased its stake in CorVel by 225.4% in the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 266 shares during the last quarter. 51.36% of the stock is owned by hedge funds and other institutional investors.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.